Method for producing recombinant human serum albumin-interferon alpha 2b

A technology of human serum albumin and human serum albumin, which is applied in the field of recombinant DNA technology to produce genetically engineered protein drugs, can solve the problems of virus suppression, restriction, and short half-life
CN101768601AActive Publication Date: 2010-07-07山东泉港药业有限公司
7 Cites 9 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
山东泉港药业有限公司
Publication Date
2010-07-07

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention relates to a method for producing recombinant human serum albumin-interferon alpha 2b of secretory expression in Pichia pastoris system, particularly to efficient expression of recombinant human serum albumin-interferon alpha 2b in Pichia pastoris and expression product purification. In the present invention, Pichia pastoris engineering bacteria containing recombinant human serum albumin-interferon alpha 2b are fermented in high density, fermented liquid is subsequently centrifuged by a high-speed centrifugal machine, and fermented supernatant liquid is collected and purified by cation exchange chromatography, hydrophobic layer chromatography and molecular sieve chromatography in a combined mode. Recombinant human serum albumin-interferon alpha 2b fusion protein produced meets the regulations of Chinese Pharmacopoeia. The present invention has the advantages of high fermentation expression rate, reasonable purification technical combination, simplified operation procedure, high yield and low production cost. The present invention meets industrial requirements.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a method for producing genetically engineered protein medicine by recombinant DNA technology, in particular to the high-efficiency expression of recombinant human serum albumin-interferon alpha 2b in Pichia pastoris and the purification of the expressed product. Background technique

[0002] Ordinary interferon (IFN) has a short half-life in the body, and interferon is quickly decomposed. During the treatment period, it cannot always maintain an effective blood drug concentration and permanently inhibit the virus, so that IFN is effective in treating hepatitis C virus (HCV). ) infection potential is limited. To overcome the above shortcomings, various types of long-acting IFN have been developed, such as polyethylene glycol IFN, albumin IFN and IFN liposomes. Among them, human albumin-interferon is one of the hotspots of new research, which has greater advantages in prolonging the half-life and being used for glycosylation mod...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More